1. Division of Pulmonary and Critical Care Medicine, University of Michigan, Ann Arbor, Michigan;
2. Department of Health Sciences, University of Leicester, Leicester, United Kingdom;
3. Genomics Division, Instituto Tecnológico y de Energías Renovables, Santa Cruz de Tenerife, Spain;
4. National Heart and Lung Institute, Imperial College London, London, United Kingdom;
5. Royal Brompton and Harefield Hospitals, Guy’s and St. Thomas’ NHS Foundation Trust, London, United Kingdom;
6. Division of Pulmonary and Critical Care Medicine and
7. Division of Respiratory Medicine and
8. Research Unit, Hospital Universitario Nuestra Señora de Candelaria, Santa Cruz de Tenerife, Spain;
9. Research Unit, Hospital Universitario de Gran Canaria Dr. Negrin, Las Palmas de Gran Canaria, Spain;
10. Division of Pulmonary and Critical Care Medicine, Vanderbilt University, Nashville, Tennessee;
11. Section of Pulmonary and Critical Care Medicine, University of Chicago, Chicago, Illinois;
12. Division of Pulmonary, Critical Care and Sleep Medicine, University of California, Davis, Davis, California;
13. Department of Surgery, College of Medicine, University of Illinois, Peoria, Illinois;
14. Division of Epidemiology and Public Health, University of Nottingham, Nottingham, United Kingdom;
15. National Institute for Health Research, Nottingham Biomedical Research Centre, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom;
16. Medical Research Council Centre for Inflammation Research, University of Edinburgh, Edinburgh, United Kingdom;
17. Respiratory Research Group, Hull York Medical School, Castle Hill Hospital, Cottingham, United Kingdom;
18. Cambridge Interstitial Lung Disease Service, Royal Papworth Hospital, Cambridge, United Kingdom;
19. Division of Pulmonary, Allergy and Critical Care Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania;
20. Center for Public Health Genomics, University of Virginia, Charlottesville, Virginia;
21. Genentech Inc., San Francisco, California;
22. Section of Pulmonary, Critical Care and Sleep Medicine, School of Medicine, Yale University, New Haven, Connecticut;
23. Division of Pulmonary, Critical Care, Allergy and Sleep Medicine, University of California, San Francisco, San Francisco, California;
24. Servei de Pneumologia, Laboratori de Pneumologia Experimental, Instituto de Investigación Biomédica de Bellvitge, Campus de Bellvitge, Universitat de Barcelona, Barcelona, Spain;
25. Centro de Investigación Biomédica en Red de Enfermedades Respiratorias, Instituto de Salud Carlos III, Madrid, Spain;
26. Translational Genomics Research Institute, Phoenix, Arizona;
27. Discovery Medicine, GlaxoSmithKline, Stevenage, United Kingdom;
28. Weill Cornell Medical Center, New York, New York;
29. National Institute for Health Research, Leicester Respiratory Biomedical Research Centre, Glenfield Hospital, Leicester, United Kingdom;
30. Division of Pulmonary and Critical Care Medicine, University of Southern California, Los Angeles, California; and
31. Facultad de Ciencias de la Salud, Universidad Fernando Pessoa Canarias, Las Palmas de Gran Canaria, Spain